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The burden of chronic diseases in global health is a surging area of research. The Global
Health Initiative at the National Heart, Lung, and Blood Institute brings together investiga-
tors from developing countries with those from the developed world to study these diseases.
In China, approximately 83 percent of all deaths in 2000 were attributed to chronic illnesses,
which are the research focuses of the Chinese center of the Global Health Initiative. To-
bacco use as well as passive smoking are modifiable risk factors in a large number of such
chronic conditions. The prevalence of smoking in China is extensive and has inseparable
ties to the economy, with tobacco taxes making up a large portion of government revenue
in poorer provinces. Methods of smoking prevention have been piloted in some Chinese
schools, which have mitigated the increase in smoking rate but have not resulted in a pri-
mary preventive effect. Efforts by the Yale Global Health Initiative and the Yale-China As-
sociation are bringing researchers together to address chronic disease in China as Yale
School of Medicine enters its 200th year.
introduction
In 2005, an estimated 35 million people
worldwide died from heart disease, stroke,
cancer, and other chronic diseases [1]. Eighty
percent of these deaths occurred in low-in-
come and middle-income countries [1]. The
World Health Organization (WHO†) projects
the leading causes of death (percentage of
total deaths) in the year 2030 in low-income
countries will include ischemic heart disease
(13.4 percent), HIV/AIDS (13.2 percent),
and cerebrovascular disease (8.2 percent) [2].
In middle-income countries, the top three
causes of death are projected as cerebrovas-
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burdencular disease (14.4 percent), ischemic heart
disease (12.7 percent), and chronic obstruc-
tive pulmonary disease (COPD) (12.0 per-
cent) [2]. While infectious diseases are still
prevalent, a large portion of deaths result from
chronic diseases. As people survive infectious
diseases, they go on to develop chronic dis-
eases. Thus, the impetus exists for global
health research to move in the direction of
chronic illnesses.
GloBal HealtH initiative at
tHe national Heart, lunG, and
Blood institute
As Yale School of Medicine enters its
200th year, its global health focus is shifting
dramatically away from one primarily in-
volving infectious diseases to one interested
in preventing chronic illnesses. As part of the
Bicentennial  Lecture  Series  at  the  Yale
School of Medicine, Dr. Elizabeth G. Nabel,
professor at Harvard Medical School and
president of Brigham and Women’s/Faulkner
Hospitals, delivered a talk entitled “Global
Health and the Chronic Diseases: Perspec-
tive, Policy and Practice” in November 2010
at The Anlyan Center. Dr. Nabel, former di-
rector  of  the  National  Heart,  Lung,  and
Blood Institute (NHLBI) at the National In-
stitutes of Health, has made tremendous con-
tributions  toward  the  understanding  of
molecular genetics of cardiovascular dis-
eases by identifying cell cycle and growth
factor proteins that regulate vascularization. 
Global  health  groups  in  Canada  and
Britain have identified 20 policy and research
priorities in the fight against chronic non-
communicable  diseases,  including  raising
public awareness, modifying risk factors, and
engaging business and community [3]. To ac-
complish this, the NHLBI has established the
Global Health Initiative, which collaborates
with overseas partners in nine centers of ex-
cellence. Their goal is to research disease fac-
tors, as Dr. Nabel does, produce trainees, and
mentor  investigators.  Awards  were  an-
nounced in June 2009 for the nine centers
with a goal to produce master-level trainees
from low- and middle-income countries that
can begin mentoring junior investigators.
Each center of excellence has a local
group that partners with an institute in the
United  States.  For  instance,  the  Beijing
branch of the George Institute for Interna-
tional Health has partnered with the Duke
Global Health Institute to oversee five hubs
of activity throughout China. As the largest
developing nation in the world, China has
shown major changes in disease pattern in
the last few decades. Non-communicable
diseases  constituted  58.2  percent  of  all
deaths in China from 1973 to 1975 [4], a
number that jumped to 82.9 percent by 2000
[4]. Population health in China has transi-
tioned epidemiologically from a preponder-
ance of infectious diseases and maternal and
perinatal illnesses to one of chronic diseases.
One important mission of the centers of ex-
cellence is to identify potential modifiable
behaviors  in  a  population  that  lead  to
chronic diseases. In her lecture, Dr. Nabel
pointed to tobacco as a significant risk fac-
tor for a large number of chronic conditions
in China, including lung cancer, coronary ar-
tery disease, hypertension, and COPD.
smokinG Prevalence and 
economics in cHina
One in three smokers in the world is a
Chinese man [5]. The total smoker number
was 350 million in China in 2002, increased
by 30 million from 1996, while the rate of
quitting only increased to 11.5 percent in 2002
from 9.4 percent in 1996 [6]. The increase in
rate of cessation and concurrent increase in
total smokers indicate a large number of indi-
viduals have begun to smoke in recent years.
The average age of initiation has become
younger,  from  23  to  19,  in  the  past  two
decades [7]. Due to the high prevalence of to-
bacco use, passive smoking is ubiquitous as
well. Passive exposure to tobacco smoke af-
fects 52.2 percent of the Chinese population,
with 67 percent of passive smokers reporting
exposure in public places [4]. 
Smoking in China is tied intimately to
the economics behind cigarette consump-
tion. China is the largest tobacco grower in
the world [5]. Domestic tobacco production
and cigarette consumption have steadily in-
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bacco increased to 2 trillion cigarettes in
2006, and 99.2 percent of domestically pro-
duced cigarettes are consumed in China,
leaving only 0.8 percent to be exported [8].
Although tobacco has the lowest economic
return as a cash crop, hefty tobacco taxes
made up 7.4 percent of the government’s
total revenue in 2003 [9]. The tobacco in-
dustry is a major source of revenue for local
governments,  especially  in  the  mid-west
provinces, where the tobacco contribution
was 40 percent to 80 percent of overall gov-
ernment revenue [9].
disease Burden from smokinG
in cHina
Smoking is a risk factor for many dis-
eases prevalent in China, including hyper-
tension,  coronary  artery  disease,  lung
cancer, and COPD. A large, prospective co-
hort  study  of  169,871  Chinese  adults
showed  significant  association  between
pack-years of smoking and death from any
cause [10]. Leading causes of death in de-
scending order were cancer, cardiovascular
disease, and respiratory disease [10]. An es-
timated 673,000 deaths were attributable to
smoking in China in 2005 [10].
Furthermore,  passive  smoking  poses
risks for non-smokers and children. Due to
the large difference in numbers of males and
females who smoke, passive smoking dis-
proportionately  affects  women.  Nearly
230,000 years of healthy life was lost in
China in 2002 due to lung cancer caused by
passive smoking [11]. Women bear 80 per-
cent of the total disease burden from passive
smoking [11]. A population-based cross-sec-
tional study in Beijing investigated cardio-
vascular disease in females who have never
smoked, 39.5 percent of whom were ex-
posed  to  secondhand  smoke  at  home  or
work [12]. After adjusting for 13 other risk
factors and environmental factors, signifi-
cant risk (odds ratio 1.31 to 2.18) was asso-
ciated  with  coronary  artery  disease,
ischemic stroke, and peripheral arterial dis-
ease  due  to  passive  smoking  [12].  The
amount of airborne nicotine was compared
among categories of establishments. While
schools and hospitals had lower concentra-
tions, restaurants, internet cafes, and karaoke
bars had the highest airborne nicotine con-
centrations [13].  
smokinG cessation and 
Prevention in cHina
The  Chinese  Congress  approved  the
Framework Convention of Tobacco Control
in 2005, which formally declared the coun-
try’s intention to enforce tobacco control
[14].  Due  to  the  preponderance  of  male
smokers in China, smoking intervention or
prevention programs mainly target males.
Furthermore, the decline in the age of initia-
tion means the most critical time is the sen-
ior  year  of  high  school  [7].  Prevention
methods derive from many models in devel-
oped countries that have also struggled with
tobacco use. For instance, a randomized trial
using a modified version of Project SMART
(Self Management And Resistance Training)
[15] was implemented in elementary schools
in Wuhan, China [16]. Students were taught
anti-tobacco policies and national smoking
statistics; they also made public commit-
ments with classmates to abstain from smok-
ing. The goal of the program is to establish a
social norm among students that smoking is
unacceptable. However, the curriculum did
not demonstrate a primary preventive effect,
even though fewer infrequent smokers pro-
gressed to become habitual smokers [16].  
Many developed countries have studied
smoking cessation methods, with individu-
alized advice from physicians and pharma-
cotherapy over multiple sessions being the
most effective [17]. The proportion of all
physicians in China who smoke is lower
than the public but remains a significant 23
percent overall (41 percent of male and 1
percent of female physicians) [18]. Report-
edly, 37 percent of current physician smok-
ers have smoked in the presence of their
patients, and fewer than 7 percent set quit
dates or use pharmacotherapy when helping
smokers quit [18]. 
At Yale, Dr. Hong Wang, assistant pro-
fessor at the Division of Global Health of
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gated the social impact of tobacco in rural
China. His research team found that smokers
in rural China forego other important ex-
penditures in order to pay for cigarettes [19].
In China, the tradition of providing the best
education for one’s children has stood for
centuries. Surprisingly, families of heavy
smokers are trading off educational expen-
diture. Spending on tobacco also negatively
affects human capital investment (health),
future farming productivity (farming equip-
ment), and financial security (savings) [19].
In short, efforts to bring about smoking ces-
sation are much needed in China.
Yale GloBal HealtH initiative
As Yale School of Medicine enters its
200th year, global health is becoming a major
worldwide  concern.  In  the  United  States,
President Barack Obama requested support
from Congress for a new global health strat-
egy in 2009, coinciding with the launch of the
Yale Global Health Initiative. The initiative
aims to unite efforts across campus and ad-
dress student and faculty interests in global
health across various nations.
In  the  wake  of  this  initiative,  global
health electives at Yale School of Medicine
have expanded to include Social, Political
and Economic Determinants of Global Health
and  Introduction  to  Research  Methods  in
Global Health, which prepares students for
further fieldwork. With China’s global role
expanding rapidly, a popular option for med-
ical students pursuing a fifth year includes
Teaching Medical English in China, which is
a combined effort through the Yale-China As-
sociation and the Yale School of Medicine to
allow Yale medical students to spend a year
teaching medical English at Xiangya Hospi-
tal in Changsha, China. While teaching Eng-
lish, students often choose to take a clinical
elective or conduct research at Xiangya at the
same time. The relationship between Yale and
Xiangya Hospital also includes exchange of
faculty and students between the two institu-
tions.
The  Yale-China  Association,  a  non-
profit organization founded in 1901, has
teamed with Yale School of Medicine to es-
tablish the Hospital and Medical Program to
develop hospital-based residency training at
Xiangya-affiliated hospitals with the support
of a group of Yale faculty members. In ad-
dition, Yale has taken part in the 10,000
Women program funded by the Goldman
Sachs Foundation to equip female Chinese
healthcare  managers  with  knowledge  to
excel in their field. The program is a part-
nership between the Tsinghua University
School of Economics and Management and
Yale School of Public Health.  
Thus,  as  global  health  emerges  as  a
field of immense interest, Yale has estab-
lished numerous ties with institutions abroad
to bring local individuals into this important
conversation. This lays a strong foundation
for continued progress in global health im-
provement in Yale School of Medicine’s
next century.
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